1. Home
  2. GRFS vs TKR Comparison

GRFS vs TKR Comparison

Compare GRFS & TKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.48

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Timken Company (The)

TKR

Timken Company (The)

HOLD

Current Price

$108.74

Market Cap

6.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
TKR
Founded
1940
1899
Country
Spain
United States
Employees
25247
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.5B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
GRFS
TKR
Price
$8.48
$108.74
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
$10.15
$110.00
AVG Volume (30 Days)
649.3K
590.0K
Earning Date
07-28-2022
05-06-2026
Dividend Yield
1.63%
1.30%
EPS Growth
N/A
N/A
EPS
N/A
4.11
Revenue
N/A
$80,100,000.00
Revenue This Year
$4.69
$4.50
Revenue Next Year
$6.49
$3.97
P/E Ratio
$18.67
$26.19
Revenue Growth
N/A
N/A
52 Week Low
$6.90
$60.85
52 Week High
$11.14
$111.39

Technical Indicators

Market Signals
Indicator
GRFS
TKR
Relative Strength Index (RSI) 53.66 61.92
Support Level $8.27 $105.18
Resistance Level $9.08 $111.19
Average True Range (ATR) 0.21 2.60
MACD 0.09 0.68
Stochastic Oscillator 67.73 91.03

Price Performance

Historical Comparison
GRFS
TKR

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.

Share on Social Networks: